New patent for Gilead Sciences drug STRIBILD

February 11, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for STRIBILD Stribild is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are thirteen…

The post New patent for Gilead Sciences drug STRIBILD appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.